GLP-1 - RAs and Bariatric Surgery

As the landscape of obesity treatment evolves, the intersection of pharmacologic therapies and surgical options becomes increasingly nuanced. In this episode, Dr. Janey Pratt and I explore when and how glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) can be used in relation to bariatric surgery. We discuss surgical candidacy criteria, benefits of bariatric surgery, long-term outcomes, and how to match treatment strategies to patient-specific characteristics, preferences, and goals.

This is the third of five posts highlighting the educational video series that Dr. Charles Vega and I collaborated on, focused on obesity management in the GLP-1 receptor agonist era. Throughout the series, we explore common clinical challenges encountered in primary care and share practical, evidence-based approaches with insights from nationally recognized experts in obesity medicine. In this episode, I have the opportunity to lead the discussion, and I encourage you to explore the other episodes in the series featuring Dr. Vega and additional experts in obesity medicine. https://bit.ly/3UuvyTu

#obesity #obesitymanagement #surgery #GLP1